Mr. Newhall joined Domain in 2009. Prior to Domain, Mr. Newhall worked for two Domain portfolio companies: Esprit Pharma and ESP Pharma. From 2005 - 2007, he worked in the corporate development group and assisted with multiple product acquisitions and Esprit Pharma’s subsequent sale to Allergan, Inc. for $370M. From 2003 - 2005, he worked at ESP Pharma. Involved in the company's Leadership Program, Mr. Newhall worked in a variety of positions including sales, finance, and marketing. During this time, he worked on a product acquisition and a pharmaceutical launch before the company was sold to Protein Design Labs for $514M. From 2001-2003, he worked at Thomas Weisel Partners as an analyst in the Semiconductor and Healthcare teams. Currently, Mr. Newhall is a member of the Young Leaders Council of the Lance Armstrong Foundation and a co-founder of the UVa Venture Summit.